Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. uri icon

Overview

publication date

  • May 15, 2020

Identity

Scopus Document Identifier

  • 85084785861

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.CAN-20-0768

PubMed ID

  • 32414837

Additional Document Info

volume

  • 80

issue

  • 10